UBS Upgrades NIO Inc.

UBS upgraded NIO Inc. to Buy from Neutral on September 16, 2025, despite the average one-year analyst price target of $6.28 suggesting a 10.60% downside from its current $7.02 share price. The company projects a significant 173.65% annual revenue increase to 189,968MM, with a non-GAAP EPS of -0.34. While the put/call ratio indicates a bullish outlook at 0.67, institutional ownership decreased by 23.53% in total shares over the last quarter, with UBS itself reducing its stake by 6.85%, contrasting with JPMorgan Chase's substantial 2,023.18% increase in its position.

Analysis

NIO Inc. presents a deeply polarized investment profile, characterized by conflicting signals from analysts, institutional investors, and its own financial projections. On one hand, UBS issued a 'Buy' upgrade on September 16, 2025, and the company projects an exceptional 173.65% increase in annual revenue. This is further supported by bullish options market sentiment, indicated by a put/call ratio of 0.67. On the other hand, this optimism is sharply contradicted by the average analyst price target of $6.28, which suggests a 10.60% downside from its last close of $7.02. Furthermore, institutional ownership has declined significantly, with the number of funds holding the stock decreasing by 5.86% and total shares owned by institutions falling 23.53% in the last quarter. Most notably, the firm issuing the upgrade, UBS Group, simultaneously reduced its own shareholdings by 6.85%. This institutional exodus is not uniform, as JPMorgan Chase dramatically increased its allocation by over 2,000%, indicating a strong, albeit minority, conviction buy. The company's fundamentals reflect a classic high-growth, high-risk scenario, with massive top-line expansion paired with continued unprofitability, as shown by the projected non-GAAP EPS of -0.34.

Key Decisions for Investors

• Investors should view the UBS 'Buy' upgrade with caution, as it is inconsistent with the consensus price target downside and UBS's own reduction in its holdings, signaling a potential disconnect between the bank's research and its asset management strategy.
• The primary investment thesis hinges on balancing the immense projected revenue growth of 173.65% against the persistent lack of profitability, making it suitable for investors with a high tolerance for risk focused on long-term growth potential.
• Monitor institutional holdings carefully, as the divergence between broad-based selling (evidenced by a 23.53% drop in total institutional shares) and concentrated, aggressive buying from entities like JPMorgan Chase suggests a battleground stock where conviction is highly polarized.